Programm | Samstag

 
09:00 — Modern heart failure therapy – any more need for ICD and etiology-based treatments?
Chairs: D. Dürschmied, Mannheim; P. Ehlermann, Heidelberg
From phenotype to genotype: important lessons from the clinics
E. Arbustini, Pavia
Sex-differences in heart failure
S. Steffens, Munich
Towards precision medicine in cardiomyopathy and heart failure
B. Heidecker, Berlin
A decade full of heart failure innovations
L. Maier, Regensburg
10:00 — SPECIAL SESSION: “10 YEARS CARDIOMYOPATHY REVOLUTIONS”
Cardiac amyloidosis – time for cure!
Chairs: N. Frey, Heidelberg; F. aus dem Siepen, Heidelberg
Diagnosis as the foundation of therapy: an advanced cookbook approach
F. Knebel, Berlin
Amyloidosis, more frequent than thought! Data from HFpEF & TAVI
P. van der Meer, Groningen
State-of-the-art treatment of amyloidosis with cardiac involvement
U. Hegenbart, Heidelberg
Long-term treatment outcomes in TTR amyloidosis
A. Yilmaz, Münster
11:00 — Keynote lecture
Chair: B. Meder, Heidelberg
Be brave and start your company!
L. Leinwand, Colorado
12:00 — LUNCH BREAK | Meet your idol in the speaker corner
13:00 — Sudden cardiac death and crazy ion channels
Chairs: A. K. Rahm, Heidelberg; P. Schweizer, Heidelberg
Genetic risk models: how to best prevent SCD
E. Schulze-Bahr, Münster
New therapeutic options in right ventricular cardiomyopathy
L. Fabritz, Hamburg
ESC cardiomyopathy registry: how can we use data to improve survival
P. Charron, Paris
Genetic testing strategies
B. Gerull, Würzburg
14:00 — Cardiomyopathies: what was achieved in…
… specific RNA- and protein-targeting – cardiac amyloidosis as a principle
S. Schwarting, Munich
… realizing genotyping as standard of care
P. van Tintelen
… modelling cardiomyopathy by in vitro systems
K. Streckfuss-Bömeke, Würzburg
… in integrating young talents
Talk by a young investigator
14:55 — Conclusion & poster prizes